Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Tunica Albuginea who wrote (4675)	1/16/1998 1:10:00 PM
From: Evan Dimmer	Respond to of 23519

Something has to come next week in the form of an upgrade. I just saw a 20,000 and a 25,000 go by (+ another 10,000 at the ask), and at least one was a buy at the ask. Next week is starting to look good.

To: Tunica Albuginea who wrote (4675)	1/16/1998 1:16:00 PM
From: LoLoLoLita	Respond to of 23519

I wouldn't call it a decisive up-side breakout until we get to 14 (the bottom of the gap space). But, at this rate, it could be today.

To: Tunica Albuginea who wrote (4675)	1/16/1998 2:30:00 PM
From: Musa Goksel Bulat	Read Replies (3) \| Respond to of 23519

Tunica Do you think patients from neighbouring countries will be buying Muse in UK after MCA approval? I think for a French citizen, going to UK and visiting a doctor and getting Muse script shouldn't be a problem. It is almost like going to New Jersey from NYC. UK could act like a distribution center for the neighbouring countries and sales in UK could be much higher than UK market alone would support. Without further approvals UK might be able to make half of the US market. Do you think this is one of the reasons why VVUS is manufacturing big quantaties at the new plant. Any comments. Musa

To: Tunica Albuginea who wrote (4675)	1/16/1998 7:33:00 PM
From: Linda Kaplan	Read Replies (2) \| Respond to of 23519

I'm just catching up on the thread now and I see, having reached 1PM today, that there was no mention of the CNBC coverage. At least three times this morning CNBC mentioned that even though VVUS was below estimates by a few cents that it was a .17 cent gain versus a big loss last year. They also said that VVUS was holding back on advertising till they could get approval of the second plant so that production could fill the orders. This story was repeated. I think it gave a picture of a company with a good future and boosted the move up today. Linda